This page is currently being updated. Please consider this provisional version.
Food and Drug Administration
FDA
- Home
- Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD), April 2019
FDA has made significant strides in developing policies that are appropriately tailored for SaMD (Software as a Medical Device) to ensure that safe and effective technology reaches users, including patients and healthcare professionals.
Share this on:
